跳至主要内容

How to start a new era of cerebral infarction treatment?

   Intravascular mechanical thrombectomy is a more advanced treatment method for cerebral infarction, and the actual treatment effect is better. Therefore, it has been widely favored by scholars and doctors in the medical field. This marks the beginning of a new era of cerebral infarction treatment. However, in this process, patients still need to maintain an objective and clear understanding of this therapy in order to better protect their health.

  1 open a new era of cerebral infarction - thrombectomy therapy

  with the level of development and progress in medical technology, in the treatment of cerebral infarction, there is a more advanced treatment methods, namely "intravascular mechanical thrombectomy therapy." This therapy occupies a very high topic in the field of neuroscience. At the same time, a large number of clinical studies have also confirmed the effect of this therapy: patients with large blood vessel occlusion have adopted endovascular mechanical thrombectomy therapy, and more than 50% have been treated after treatment. Good recovery, able to return to society normally and start a new life. Before the introduction of mechanical endovascular thrombectomy therapy, it is hard to imagine that the treatment of cerebral infarction can achieve such a curative effect. It also proves that the emergence of mechanical thrombectomy therapy has successfully opened up a new approach in the treatment of cerebral infarction. era. The following is a brief introduction to intravascular mechanical thrombectomy therapy: The

  so-called intravascular mechanical thrombectomy therapy is simply to puncture the patient’s femoral artery, and then use a microcatheter to put the thrombectomy device into the patient’s blood vessel , Driven by the blood, the thrombus removal device is sent to the occlusion position of the blood vessel, and then the thrombus in the blood vessel is smoothly removed by wrapping and adhesion of the thrombus removal device, and the human cerebrovascular channel is opened. Compared with traditional intravenous thrombolytic therapy, intravascular mechanical thrombectomy therapy is simpler and more direct. It can directly reach the lesion and eliminate the hidden danger of cerebral infarction from the root cause, that is, directly remove the emboli in the blood, so it can help the patient better recover Health, improve the treatment effect of cerebral infarction.

  2 How to open a new era of cerebral infarction

  due to the mechanical embolectomy Endovascular therapy has many advantages, many doctors have produced some extreme idea that traditional intravenous thrombolytic therapy is the "twilight", endovascular therapy is a mechanical thrombectomy " Kingly" Is this really the case? Although this therapy does have a good effect on patients with cerebral infarction, it is not suitable for all patients with cerebral infarction. This requires a clear understanding of the following:

  On the one hand, intravascular mechanical thrombectomy therapy is only suitable for patients with large blood vessel occlusion. From the perspective of the principle of intravascular mechanical thrombectomy therapy, it mainly relies on thrombectomy devices to take the thrombus away from the blood vessel. However, due to the size of the thrombectomy device and the resolution of the DSA machine, the thrombectomy device can only work in large blood vessels and this therapy can be effective. Among patients with cerebral infarction, only about 30% of patients belong to large vessel occlusion, that is to say, this kind of mechanical endovascular thrombectomy therapy is only suitable for 30% of patients with cerebral infarction. In contrast to traditional intravenous thrombolytic therapy, in theory, as long as the blood can reach the place, intravenous thrombolysis can work, so it is suitable for almost all patients with cerebral infarction.

  On the other hand, we also need to further understand which patients are suitable for endovascular mechanical thrombectomy and which patients are not suitable for this therapy.

  In the latest "Guidelines for the Diagnosis and Treatment of Early Endovascular Intervention for Acute Ischemic Stroke in China 2018", the following situations of patients with cerebral infarction are proposed, which are suitable for choosing endovascular mechanical thrombectomy:

  If the patient is due to the M1 segment of the cerebral artery and the neck Acute cerebral infarction caused by arterial occlusion. And before the onset of the patient, the mRS score is above 1 point, and the ASPECTS or NIHSS score is within 6 points, and the patient can choose to use arterial thrombus removal for the treatment of acute cerebral infarction. The mRS score is simply used to evaluate the ability of patients to recover brain nerve function after cerebral infarction. It is generally divided into seven grades. The higher the grade, the more difficult it is for patients to recover after cerebral infarction, and the disability rate is also Higher. ASPECTS is used to evaluate the changes of cerebral arterial blood supply in patients with early ischemia after acute cerebral infarction. Generally, the lower the score, the more serious the cerebral artery ischemia, and the more serious the consequences. NIHSS assesses the degree of damage to the brain nerves of a patient after the onset of cerebral infarction. Generally, the higher the score, the more serious the nerve damage will be and the greater the threat to life safety.

  If the patient undergoes acute cerebral infarction, both intravenous thrombolytic therapy and arterial mechanical thrombectomy are suitable for treatment, then it is recommended to use intravenous thrombolysis for treatment first, and then cooperate with arterial mechanical thrombectomy for bridging treatment. It is recommended to directly use the arterial mechanical thrombectomy treatment method, because the arterial mechanical thrombectomy treatment is still a relatively new treatment method. The thrombolytic device is delivered to the lesion to achieve the corresponding effect. Therefore, it is still necessary to use intravenous thrombolysis to soften and reduce the patient’s thrombus, so that the follow-up is more conducive to the implementation of the arterial mechanical thrombectomy treatment method and improves The effect of the therapy. And for large vessel occlusion, intravenous thrombolysis is not completely useless. There is still a 17% probability of directly opening the patient's occluded large blood vessel. Therefore, if the arterial mechanical thrombolysis treatment is directly used, the patient may miss the best treatment opportunity .

  If the location of the patient's cerebral infarction is the M2 segment of the anterior cerebral artery, vertebral artery, basilar artery, and middle cerebral artery, arterial thrombus removal can also be considered.

  For patients with the following conditions, mechanical arterial thrombolysis is not recommended: (1) Patients with cerebral infarction have obvious active bleeding tendency; (2) Patients with severe heart, liver, and kidney dysfunction; (3) The patient's blood sugar is lower than 2.7 mmol/L, or the patient has diabetes, and the blood sugar is higher than 22.2 mmol/L; (4) The patient has severe hypertension.

  3 Summary

  In summary, the emergence of endovascular mechanical thrombectomy therapy, significantly enhance the therapeutic effect of cerebral infarction, patients recover better after treatment, it can be said to open a new era in the treatment of cerebral infarction. However, this treatment method still has certain limitations. It is not possible to directly ignore the advantages of traditional intravenous thrombolytic therapy because of the good treatment. We still need to improve our understanding and rationally use cerebral infarction treatment methods to achieve better treatment results.


评论

此博客中的热门博文

Moroccan football team: "The most familiar stranger"

   When I was still in college ten years ago, I led a sightseeing group of more than 30 Moroccan students. Before meeting them, my general impression of the Moroccans was that they are from North Africa but closer to the Arab world. They have religious beliefs, are used to worship, and are inextricably linked with France.   When I saw the real person, I realized that the North Africans in front of me were actually a group of children playing with each other and having fun in time. They were about the same age as me at the time. I have all kinds of nicknames and nicknames. During the process of taking them to Badaling, the Summer Palace and Houhai, two classmates and I, together with more than 30 Moroccan students, realized "cultural integration" and "world unity" in the small group to some extent.   During the World Cup in Qatar, I was surprised to find that the little-known Morocco team, which was eliminated in the group stage of the last World Cup, after miraculou

Zeigarnik effect

  As a freelancer, you have to fight procrastination every day. "I've made up my mind many times, but I just can't change it. Is it because I'm slow or slow?". In fact, many procrastinations are irrational. Many obstructions are imagined by myself. So distract, postpone, avoid confrontation. It's cool to procrastinate, and it's cool to procrastinate all the time, so I can't do it. Concentration is also related to physical strength. When the physical strength is exhausted, it is even more difficult to concentrate. You’ll tell yourself: I’m too tired to do this—okay, another perfect procrastination.   In 1927, Bruma Zeigarnik's senior research found that people are more likely to care about unfinished and interrupted work than completed work. This is the Zeigarnik effect. For example, we often don't care much about what we have got, but we will especially cherish what we have worked hard but haven't got. Therefore, the TV series will tell you

Hebei Xingang Pharmaceutical Co., Ltd.

Hebei Xingang Pharmaceutical Co., Ltd is located in the industrial park of Zhao County, Shijiazhuang, Hebei, near the world-famous ZhaoZhou Bridge. Our facility neighbors the Qinyin Expressway and 308 National Highway on the east, and it neighbors the Jingzhu Expressway and 107 National Highway on the west. It is located 30 km from Shijiazhuang High-speed Train Station and 50 km from Shijiazhuang International Airport. Our company mainly focuses on the research, production and retail of rifamycin and its derivatives, and pharmaceutical raw materials and intermediates. Our products mainly include, Rifamycin S Sodium, Rifamycin S, 3-Formyl Rifamycin SV, Rifamycin SV Sodium, Rifampicin, Rifandine, Rifaximin, Rifapentine, Rifabutin, Rilmenidine, and so on. We are currently the world’s main manufacturer of anti-tuberculosis drugs and rifamycin and its derivatives. Hebei Xingang Pharmaceutical Co., Ltd was established in 1996. Upon establishment, the company had a clear developmental goal o